Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #419291 on Anavex Life Sciences Corp (AVXL)
nidan7500
06/19/23 8:22 AM
#419292 RE: nidan7500 #419291
https://alz-journals.onlinelibrary.wiley.com/toc/15525279/2023/19/S7 Study of the mechanism of action of Blarcamesine (ANAVEX®2-73): Whole blood transcriptomics analysis identifies treatment impact on compensatory pathways by restoring key neurodegenerative pathways functionality, including Alzheimer’s disease pathway Coralie Williams, Martin Kindermans, Frédéric Parmentier, Federico Goodsaid, Edward Hammond, Christopher U Missling, Mohammad Afshar First published: 16 June 2023 https://doi.org/10.1002/alz.059024
[img][/img]